Collaboration for rare disease drug discovery research [v1; ref status: indexed, http://f1000r.es/4l6]
Rare disease research has reached a tipping point, with the confluence of scientific and technologic developments that if appropriately harnessed, could lead to key breakthroughs and treatments for this set of devastating disorders. Industry-wide trends have revealed that the traditional drug discov...
Main Authors: | Nadia K. Litterman, Michele Rhee, David C. Swinney, Sean Ekins |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2014-10-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/3-261/v1 |
Similar Items
-
Small molecules with antiviral activity against the Ebola virus [v1; ref status: indexed, http://f1000r.es/523]
by: Nadia Litterman, et al.
Published: (2015-02-01) -
Data publication consensus and controversies [v3; ref status: indexed, http://f1000r.es/4ja]
by: John Kratz, et al.
Published: (2014-10-01) -
Data publication consensus and controversies [v2; ref status: indexed, http://f1000r.es/3hi]
by: John Kratz, et al.
Published: (2014-05-01) -
The Resource Identification Initiative: A cultural shift in publishing [v1; ref status: indexed, http://f1000r.es/5fj]
by: Anita Bandrowski, et al.
Published: (2015-05-01) -
FDA approved drugs as potential Ebola treatments [v2; ref status: indexed, http://f1000r.es/554]
by: Sean Ekins, et al.
Published: (2015-03-01)